The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-N-((2S,3R)-1-((S)-1-(4-(aminomethyl)phenyl)-4-(methylsulfonyl)but-3-en-2-ylamino)-3-hydroxy-1-oxobutan-2-yl)-2-((S)-2-azido-3-phenylpropanamido)-4-methylpentanamide ID: ALA4590398
PubChem CID: 155567712
Max Phase: Preclinical
Molecular Formula: C31H43N7O6S
Molecular Weight: 641.80
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)N=[N+]=[N-])C(=O)N[C@H](C(=O)N[C@H](/C=C/S(C)(=O)=O)Cc1ccc(CN)cc1)[C@@H](C)O
Standard InChI: InChI=1S/C31H43N7O6S/c1-20(2)16-26(35-30(41)27(37-38-33)18-22-8-6-5-7-9-22)29(40)36-28(21(3)39)31(42)34-25(14-15-45(4,43)44)17-23-10-12-24(19-32)13-11-23/h5-15,20-21,25-28,39H,16-19,32H2,1-4H3,(H,34,42)(H,35,41)(H,36,40)/b15-14+/t21-,25-,26+,27+,28+/m1/s1
Standard InChI Key: OSCQGDIKEUNOAP-XNQSZOFZSA-N
Molfile:
RDKit 2D
45 46 0 0 0 0 0 0 0 0999 V2000
32.5226 -17.3633 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
32.9353 -18.0731 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
33.3437 -17.3608 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.5670 -18.4859 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.2747 -18.0773 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.9824 -18.4859 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.2747 -17.2601 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
25.8593 -18.0773 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.1516 -18.4859 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.1516 -19.3030 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
28.6901 -18.0773 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.3978 -18.4859 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.1055 -18.0773 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.3978 -19.3030 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
30.8132 -18.4859 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.5209 -18.0773 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.8132 -19.3030 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.2286 -18.4859 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.6441 -18.4859 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.5209 -19.7116 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.5169 -20.5299 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.2238 -20.9384 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.9325 -20.5298 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.9298 -19.7083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.2224 -19.3035 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.6407 -20.9374 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.3479 -20.5279 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.4477 -18.0773 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.7435 -18.4854 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.6901 -17.2601 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.5670 -19.3030 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.2747 -19.7116 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.2747 -20.5288 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.9824 -19.3030 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.4479 -17.2601 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.0351 -18.0779 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.0376 -17.2603 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.3301 -16.8530 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.6221 -17.2628 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.6260 -18.0842 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.3341 -18.4879 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.1558 -16.8517 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.8612 -16.4388 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.3978 -16.8515 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.9824 -16.8515 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 1 0
5 6 1 0
5 7 2 0
4 8 1 0
8 9 1 0
9 10 2 0
6 11 1 0
11 12 1 1
12 13 1 0
12 14 2 0
13 15 1 0
15 16 1 0
15 17 1 6
16 18 2 0
18 2 1 0
2 19 1 0
17 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 20 1 0
23 26 1 0
26 27 1 0
29 28 1 0
9 28 1 0
11 30 1 0
4 31 1 6
31 32 1 0
32 33 1 0
32 34 1 0
28 35 1 6
29 36 1 0
36 37 2 0
37 38 1 0
38 39 2 0
39 40 1 0
40 41 2 0
41 36 1 0
35 42 2 0
42 43 2 0
30 44 1 1
30 45 1 0
M CHG 2 42 1 43 -1
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 641.80Molecular Weight (Monoisotopic): 641.2996AlogP: 2.05#Rotatable Bonds: 17Polar Surface Area: 216.45Molecular Species: ZWITTERIONHBA: 8HBD: 5#RO5 Violations: 1HBA (Lipinski): 13HBD (Lipinski): 6#RO5 Violations (Lipinski): 3CX Acidic pKa: -10.27CX Basic pKa: 9.29CX LogP: 1.23CX LogD: -0.75Aromatic Rings: 2Heavy Atoms: 45QED Weighted: 0.10Np Likeness Score: 0.35
References 1. Xin BT, Huber EM, de Bruin G, Heinemeyer W, Maurits E, Espinal C, Du Y, Janssens M, Weyburne ES, Kisselev AF, Florea BI, Driessen C, van der Marel GA, Groll M, Overkleeft HS.. (2019) Structure-Based Design of Inhibitors Selective for Human Proteasome β2c or β2i Subunits., 62 (3): [PMID:30657666 ] [10.1021/acs.jmedchem.8b01884 ]